Nigeria: The COVID-19 vaccine for Nigeria sponsored by the Tertiary Education Trust Find will be ready for a clinical trial in November 2022. The Fund is developing efforts to make vaccines available for the people of the country.
The project named Accelerated Development of COVID-19 Vaccines Using Innovative Technological Approach is known as the mega research grant intervention. It is a collaborative effort which involves cluster researchers from five different institutions to consolidate problem-solving research and promote innovation in Nigeria.
It would be stated that TETFund will be awarded a total sum of N1.250bn which will be distributed to four clusters of researchers. One of the clusters, which is the Vaccine Production Cluster, got a total grant of N450 Million.
The Vaccine Production Cluster will be made by the researchers from the National Veterinary Research Institute, Vom, Usman Danfodiyo University Sokoto, Faculty of Veterinary Medicine, University of Jos, Nigerian Institute of Medical Research Lagos and National Research Institute for Chemical Technology, Zaria.
Vice Chancellor of Usman Danfodiyo University, Sokoto, Professor Lawal Suleiman Bilbis, who led the team of researchers to brief the Executive Secretary of TETFund, Sonny Echono on the progress since then, explained that they could be able to make the breakthrough through the maximum support of the Fund.
He recalled how the COVID-19 pandemic devastated and unleashed untold hardship on humanity globally, noting that Nigeria was only saved by divine intervention since the nation was not prepared for such eventuality.
